Federal aid cuts are dangerously shortsighted, given that antimicrobial resistance poses a significant threat to global security. The economic modeling shows that every dollar invested in AMR prevention delivers a 28:1 return, making these programs among the most cost-effective interventions available. Cutting international AMR surveillance now virtually guarantees higher resistance rates worldwide, ultimately costing developed nations far more in the long run.

Fiscal responsibility requires tough choices, and domestic priorities must take precedence during challenging economic times. The partnerships and expertise from programs like the Fleming Fund will continue even without direct funding, allowing countries to develop their own surveillance capabilities. Defense spending increases are essential for national security, and the private sector can play a crucial role in filling gaps in global health initiatives.